SCHEMBL4357149

SCHEMBL4357149

CCOC(=O)c1coc(-c2cn(CC3CCCCC3)c3ccc(Cl)cc23)n1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.47
CNR2 P34972 2/20 0.42
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PDE4A P27815 4/20 0.37
PDE4B Q07343 4/20 0.37
PDE4C Q08493 4/20 0.37
PDE4D Q08499 4/20 0.37
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
LMNA P02545 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
XDH P47989 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3588519 0.96 CNR1 (0.44) CNR1CNR2ALDH1A1KDM4EHPGD
SCHEMBL4357106 0.87 CNR1 (0.47) CNR1CNR2PDE4APDE4BPDE4C
SCHEMBL3602199 0.85 PTGDR2 (0.41) ALDH1A1KDM4EHPGDALOX15TSHR
SCHEMBL3596646 0.83 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDALOX15TSHR
SCHEMBL3591440 0.82 CNR1 (0.46) CNR1CNR2XDH
SCHEMBL4357082 0.82 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDALOX15TSHR
SCHEMBL4350902 0.82 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDALOX15TSHR
SCHEMBL4357086 0.79 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDALOX15TSHR
SCHEMBL3593293 0.76 CNR2 (0.48) CNR1CNR2
SCHEMBL3591950 0.75 CNR1 (0.45) CNR1CNR2XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281152-A1 Indole Compounds Having Affinity to the EP1 Receptor GLAXO GROUP LIMITED (GB) 2009-11-12 US disclosed
US-20090281152-A1 Indole Compounds Having Affinity to the EP1 Receptor GLAXO GROUP LIMITED (GB) 2009-11-12 US disclosed
US-20090281152-A1 Indole Compounds Having Affinity to the EP1 Receptor GLAXO GROUP LIMITED (GB) 2009-11-12 US disclosed
WO-2008006794-A1 INDOLE COMPOUNDS HAVING AFFINITY TO THE EP1 RECEPTOR GLAXO GROUP LIMITED (GB) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281152-A1 Indole Compounds Having Affinity to the EP1 Receptor PTGER1, PTGER2, PTGER3 CNR1 7/4885CNR2 20/4885ALDH1A1 608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.